Alpha 2.0
Login Register
» Authors » Denise M Boudreau

Denise M Boudreau

Explore the profile of Denise M Boudreau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 2178
Followers 0
Related Specialties
Public Health
Oncology
Pharmacology
Top 10 Co-Authors
Onchee Yu
Jessica Chubak
Diana S M Buist
Jennifer F Bobb
Katharine A Bradley
Cynthia I Campbell
Andrew J Saxon
Marsha A Raebel
Jordan M Braciszewski
Paul A Fishman
Published In
Pharmacoepidemiol Drug Saf
Cancer Causes Control
Breast Cancer Res Treat
Am J Epidemiol
Cancer Epidemiol Biomarkers Prev
Affiliations
Soon will be listed here.
Recent Articles
1.
Telemedicine Use Before and During the COVID-19 Pandemic in People with Alzheimer's Disease, Multiple Sclerosis, or Parkinson's Disease: A Cross-Sectional Study Using US Commercial Claims Data
Patel A, Schuldt R, Boudreau D, Cobb B, Win N, McGinley M
Telemed Rep . 2024 Aug; 5(1):247-255. PMID: 39184874
Background: During the COVID-19 pandemic, use of telemedicine (TM) increased dramatically, but it is unclear how use varies by characteristics of people with Alzheimer's disease (AD), multiple sclerosis (MS), or...
2.
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial
Bobb J, Idu A, Qiu H, Yu O, Boudreau D, Wartko P, et al.
Drug Alcohol Depend . 2024 Jun; 261:111350. PMID: 38875880
Background: Patients with opioid use disorder (OUD) have increased emergency and hospital utilization. The PROUD trial showed that implementation of office-based addiction treatment (OBAT) increased OUD medication treatment compared to...
3.
Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial
Wartko P, Bobb J, Boudreau D, Matthews A, McCormack J, Lee A, et al.
JAMA Intern Med . 2023 Oct; 183(12):1343-1354. PMID: 37902748
Importance: Few primary care (PC) practices treat patients with medications for opioid use disorder (OUD) despite availability of effective treatments. Objective: To assess whether implementation of the Massachusetts model of...
4.
STRategies to Improve Pain and Enjoy life (STRIPE): results of a pragmatic randomized trial of pain coping skills training and opioid medication taper guidance for patients on long-term opioid therapy
Wartko P, Krakauer C, Turner J, Cook A, Boudreau D, Sullivan M
Pain . 2023 Aug; 164(12):2852-2864. PMID: 37624901
Because long-term opioid therapy (LtOT) for chronic pain has uncertain benefits and dose-dependent harms, safe and effective strategies for opioid tapering are needed. Adapting a promising pilot study intervention, we...
5.
Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems
Wartko P, Qiu H, Idu A, Yu O, McCormack J, Matthews A, et al.
BMC Health Serv Res . 2022 Dec; 22(1):1593. PMID: 36581845
Background: Pragmatic primary care trials aim to test interventions in "real world" health care settings, but clinics willing and able to participate in trials may not be representative of typical...
6.
Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics
Gray S, Fornaro R, Turner J, Boudreau D, Wellman R, Tannenbaum C, et al.
J Am Geriatr Soc . 2022 Dec; 71(5):1580-1586. PMID: 36546768
Background: While many studies have assessed and measured patient attitudes toward deprescribing, less quantitative research has addressed the provider perspective. We thus sought to describe provider knowledge, beliefs, and self-efficacy...
7.
Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder
Braciszewski J, Idu A, Yarborough B, Stumbo S, Bobb J, Bradley K, et al.
Psychiatr Serv . 2022 Jun; 73(12):1330-1337. PMID: 35707859
Objective: The authors sought to characterize the 3-year prevalence of mental disorders and nonnicotine substance use disorders among male and female primary care patients with documented opioid use disorder across...
8.
Safety of opioid prescribing among older cancer survivors
Salz T, Mishra A, Gennarelli R, Lipitz-Snyderman A, Moryl N, Tringale K, et al.
Cancer . 2021 Oct; 128(3):570-578. PMID: 34633662
Background: Cancer survivors receive more long-term opioid therapy (LTOT) than people without cancer, but the safety of LTOT prescribing is unknown. Methods: Opioid-naive adults aged ≥66 years who had been...
9.
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems
Bagley S, Chavez L, Braciszewski J, Akolsile M, Boudreau D, Lapham G, et al.
Addict Sci Clin Pract . 2021 Jul; 16(1):46. PMID: 34233750
Purpose: Little is known about prevalence and treatment of OUD among youth engaged in primary care (PC). Medications are the recommended treatment of opioid use disorder (OUD) for adolescents and...
10.
STRategies to Improve Pain and Enjoy life (STRIPE): Protocol for a pragmatic randomized trial of pain coping skills training and opioid medication taper guidance for patients on long-term opioid therapy
Wartko P, Boudreau D, Turner J, Cook A, Wellman R, Fujii M, et al.
Contemp Clin Trials . 2021 Jul; 110:106499. PMID: 34217889
High-dose, long-term opioid therapy (LtOT) is associated with risk for serious harms. Rapid opioid discontinuation may lead to increased pain, psychological distress, and illicit opioid use, but gradual, supported opioid...